We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Adaptive Biotechnologies Corp
20 own
15 watching
Current Price
$7.64
$-0.06
(-0.78%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,102.3M
52-Week High
13.21
52-Week Low
5.955
Average Volume
1M
Dividend Yield
--
P/E Ratio
7.59259259
Market Capitalization1,102.3M52-Week High13.2152-Week Low5.955Average Volume1MDividend Yield--P/E Ratio7.59259259What does the Adaptive Biotechnologies Corp do?
Adaptive Biotechnologies Corporation develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions that inform current and future clinical trials, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. It serves the life sciences research, clinical diagnostics, and drug discovery customers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.
Read More
How much money does Adaptive Biotechnologies Corp make?
News & Events about Adaptive Biotechnologies Corp.
Globe Newswire
1month ago
Collaboration will cover existing and future programs to aid in the development and commercialization of investigational medicines for hematologic malignanciesSEATTLE, April 12, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company ...
Ticker Report
3 months ago
Adaptive Biotechnologies Co. (NASDAQ:ADPT Get Rating) was the recipient of a large decrease in short interest in January. As of January 31st, there was short interest totalling 4,750,000 shares, a decrease of 12.4% from the January 15th total of 5,420,000 shares. Based on an average daily ...
Ticker Report
5 months ago
Adaptive Biotechnologies Co. (NASDAQ:ADPT Get Rating) was the recipient of a large decline in short interest in December. As of December 15th, there was short interest totalling 4,730,000 shares, a decline of 11.1% from the November 30th total of 5,320,000 shares. Based on an average trading...
Zolmax
5 months ago
Adaptive Biotechnologies Co. (NASDAQ:ADPT Get Rating) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 4,730,000 shares, a decrease of 11.1% from the November 30th total of 5,320,000 shares. Based on an average daily trading...
PR Newswire
5 months ago
Thinking about buying stock in HTG Molecular Diagnostics, 180 Life Sciences, Six Flags Entertainment, Under Armour, or Adaptive Biotechnologies? Thinking about buying stock in HTG Molecular Diagnostics, 180 Life Sciences, Six Flags Entertainment, Under Armour, or Adaptive Biotechnologies? PR...
Frequently Asked Questions
Frequently Asked Questions
What is Adaptive Biotechnologies Corp share price today?
Can Indians buy Adaptive Biotechnologies Corp shares?
How can I buy Adaptive Biotechnologies Corp shares from India?
Can Fractional shares of Adaptive Biotechnologies Corp be purchased?
What are the documents required to start investing in Adaptive Biotechnologies Corp stocks?
What is today’s traded volume of Adaptive Biotechnologies Corp?
What is today’s market capitalisation of Adaptive Biotechnologies Corp?
What is the 52-Week High and Low Range of Adaptive Biotechnologies Corp?
What percentage is Adaptive Biotechnologies Corp down from its 52-Week High?
What percentage is Adaptive Biotechnologies Corp up from its 52-Week Low?
Current Price
$7.64
$-0.06
(-0.78%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.